Intra-Articular Corticosteroid Market To Continue With Innovative Streak

New York, United States, 2022-May-16 — /EPR Network/ —

The global Intra-Articular Corticosteroid Market is there to grow at a noteworthy In Upcoming Years. These days, pre-empt process breakdowns by making use of AI are the ongoing trend. Regulatory compliance is also being adhered to using data masking. Personalized smart videos are being used to render proper member communication. These, and many such digitally transformative approaches are being followed in the enterprise as of now and the scenario is expected to remain the same even going forward.

Over the past decades, intra-articular corticosteroid has been widely used in knee osteoarthritis. Intra-articular corticosteroid is a medicine which is directly injected into the joint space of the painful, inflamed arthritic joint. Intra-articular corticosteroid is majorly used for the treatment of patients with knee osteoarthritis.

Intra-articular corticosteroid injections provide a short term reduction in osteoarthritis pain. An intra-articular corticosteroid is generally given when the pain has not responded to more conservative treatments like physical therapy, pain relievers, and oral anti-inflammatory drugs.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/28207

The increasing prevalence of osteoarthritis is considered as an important factor in driving the growth of the global intra-articular corticosteroid market. Osteoarthritis is a disabling joint disorder associated with a breakdown of the cartilage of the joints and is affecting millions of people. Globally, there are around more than 8.9 million fractures caused by osteoporosis. It is expected to be the most common cause of disability in adults.

Furthermore, the increasing number of road accidents and sports-related injuries are also driving the market growth of intra-articular corticosteroid market.

However, dropout rates were increased due to the side effects (like local site reaction, increase in blood glucose levels and blood pressure, and infection) associated with the intra-articular corticosteroid. This has reduced the adoption rate among the targeted population and further hampered the growth of the global intra-articular corticosteroid market globally.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/28207

Market Segmentation

Based on the drug type	Methylprednisolone Acetate Triamcinolone Acetate Triamcinolone Hexacetonide Dexamethasone Others
Based on the application	Osteoarthritis Rheumatoid Arthritis Acute Gout Others
Based on the end user	Institutional sales Clinics Hospitals Retail Sales Drug Stores Hospital Pharmacies Online Pharmacies Retail Pharmacies

Access Full Report@ https://www.persistencemarketresearch.com/checkout/28207

North America intra-articular corticosteroid market and Europe intra-articular corticosteroid market are collectively expected to hold maximum market share in the global intra-articular corticosteroid market. This is due to the rising prevalence of knee osteoarthritis and the availability of high-quality healthcare facilities.

South Asia intra-articular corticosteroid market is anticipated to hold significant market share in the global intra-articular corticosteroid market due to the growing number of drug development activities. Emerging countries of the developing regions are expected to grow with a significant growth rate.

The key players present in the global intra-articular corticosteroid market are Flexion Therapeutics, Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG (Sandoz), Teva Pharmaceutical Industries Ltd., Cardinal Health, Inc., Terrain Pharmaceuticals, LLC, Allergan plc, and others.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com